The results of the survey among the parents of patients with achondroplasia on the role of vosoritide therapy
Introduction Achondroplasia (ACP) is a common skeletal dysplasia. Vozoritide is the first drug that has an effect on the pathogenesis of impaired enchondral growth in achondroplasia. Clinical trials of the second and third phases have shown its effectiveness according to the latest literature data...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Russian Ilizarov Scientific Center for Restorative Traumatology and Orthopaedics
2021-08-01
|
Series: | Гений oртопедии |
Subjects: |